Solara Active Pharma Sciences (NSE:SOLARAPP) COGS-to-Revenue : 0.45 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Solara Active Pharma Sciences COGS-to-Revenue?

Solara Active Pharma Sciences's Cost of Goods Sold for the three months ended in Dec. 2024 was ₹1,349 Mil. Its Revenue for the three months ended in Dec. 2024 was ₹3,003 Mil.

Solara Active Pharma Sciences's COGS to Revenue for the three months ended in Dec. 2024 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Solara Active Pharma Sciences's Gross Margin % for the three months ended in Dec. 2024 was 55.09%.

Solara Active Pharma Sciences COGS-to-Revenue Historical Data

The historical data trend for Solara Active Pharma Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences COGS-to-Revenue Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.48

0.55

0.59

0.68

Solara Active Pharma Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															1.02	0.78	0.55	0.50	0.45

Solara Active Pharma Sciences COGS-to-Revenue Calculation

Solara Active Pharma Sciences's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	8385.1	/	12383.9
	=	0.68

Solara Active Pharma Sciences's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1348.6	/	3003.1
	=	0.45

Solara Active Pharma Sciences (NSE:SOLARAPP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Solara Active Pharma Sciences's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1348.6 / 3003.1
	=	55.09 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Solara Active Pharma Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARAPP) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

890202:India SOLARA:India 541540:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines